BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8634993)

  • 1. Ovarian cancer screening. The role of ultrasound in early detection.
    Karlan BY; Platt LD
    Cancer; 1995 Nov; 76(10 Suppl):2011-5. PubMed ID: 8634993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The status of ultrasound and color Doppler imaging for the early detection of ovarian carcinoma.
    Karlan BY
    Cancer Invest; 1997; 15(3):265-9. PubMed ID: 9171861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.
    Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE
    Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound screening in women at risk for ovarian cancer.
    Andolf E
    Clin Obstet Gynecol; 1993 Jun; 36(2):423-32. PubMed ID: 8513636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current status of ultrasound and color Doppler imaging in screening for ovarian cancer.
    Karlan BY; Platt LD
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S28-33. PubMed ID: 7835806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer screening by transvaginal color Doppler ultrasonography.
    Rampone B; Rampone A; Tirabasso S; Panariello S; Rampone N
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):125-8. PubMed ID: 11526707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound.
    Vuento MH; Pirhonen JP; Mäkinen JI; Laippala PJ; Grönroos M; Salmi TA
    Cancer; 1995 Oct; 76(7):1214-8. PubMed ID: 8630900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound and ovarian cancer.
    Cohen L; Fishman DA
    Cancer Treat Res; 2002; 107():119-32. PubMed ID: 11775447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
    van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
    Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for ovarian cancer: what are the optimal surrogate endpoints for clinical trials?
    Karlan BY
    J Cell Biochem Suppl; 1995; 23():227-32. PubMed ID: 8747401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on ovarian cancer screening.
    Munkarah A; Chatterjee M; Tainsky MA
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):22-6. PubMed ID: 17218847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
    Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
    Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound screening for the early detection of ovarian cancer.
    DePriest PD; DeSimone CP
    J Clin Oncol; 2003 May; 21(10 Suppl):194s-199s. PubMed ID: 12743134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.
    Bourne TH; Campbell S; Reynolds KM; Whitehead MI; Hampson J; Royston P; Crayford TJ; Collins WP
    BMJ; 1993 Apr; 306(6884):1025-9. PubMed ID: 8490496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer screening: a look at the evidence.
    Fields MM; Chevlen E
    Clin J Oncol Nurs; 2006 Feb; 10(1):77-81. PubMed ID: 16482731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for ovarian cancer in the general population.
    Chu CS; Rubin SC
    Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):307-20. PubMed ID: 16364690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
    Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
    Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.
    Menon U; Talaat A; Rosenthal AN; Macdonald ND; Jeyerajah AR; Skates SJ; Sibley K; Oram DH; Jacobs IJ
    BJOG; 2014 Dec; 121 Suppl 7():35-9. PubMed ID: 25488086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of transvaginal ultrasound color flow imaging and Doppler waveform analysis in differentiating between benign and malignant ovarian tumors.
    Anandakumar C; Chew S; Wong YC; Chia D; Ratnam SS
    Ultrasound Obstet Gynecol; 1996 Apr; 7(4):280-4. PubMed ID: 8726882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is ultrasound screening for ovarian cancer possible in 1998?].
    Descamps P; Fondrinier E; Biquard F; Binelli C; Lepinard C; Loisel D; Crvencowitcz G; Platt LD; Karlan BY
    J Gynecol Obstet Biol Reprod (Paris); 1998 Sep; 27(5):476-81. PubMed ID: 9791573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.